Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in acute coronary syndromes undergoing staged PCI
ACTRN12615000485538Phase 4Completed
- Sponsor
- St Vincent's Hospital Melbourne
- Start
- Jul 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of colchicine in acute coronary syndrome (ACS) and coronary arteriosclerosis (2 arms), sponsored by St Vincent's Hospital Melbourne. Primary endpoints: Periprocedural myocardial infarction and Major adverse cardiovascular events. Started Jul 2017; status: completed.
02
Drugs
colchicine
03
Conditions
acute coronary syndrome (ACS)coronary arteriosclerosis
Beyond the preview
Go deeper on ACTRN12615000485538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000485538.